Plain-English translation of NCT06800937 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers want to understand how the body chemistry of women with anorexia nervosa differs from healthy women—specifically, they're looking at a group of fat-like molecules called sphingolipids in the blood. By identifying these differences, doctors hope to customize nutrition rehabilitation programs to work better and help patients recover more effectively, especially over the long term.
Anorexia nervosa is a serious eating disorder that affects the body in complex ways. This study exists because doctors don't yet fully understand the specific body chemistry changes that happen with this condition, which means current treatment approaches may not be as effective as they could be.
You likely qualify if…
You likely don't qualify if…
If you have anorexia nervosa, you would be part of the main study group being cared for at the hospital's eating disorder division. You would complete questionnaires about your eating habits, mood, and any thoughts of self-harm, plus have your hormone levels measured through blood work. The research team will also compare your results with blood samples from healthy women volunteers to identify the differences they're studying.
AI-generated summary from trial data · Jul 5, 2026 · Not medical advice
Italy
Enrollment target
~60 participants
Started
June 2024
Primary completion
June 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Sex
Female only
Last updated on clinicaltrials.gov in March 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Alessandro Sartorio, MD
Istituto Auxologico Italiano
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.